You’re invited for EHN Canada’s next educational webinar: rTMS & Ketamine: Treatment Resistant Depression with Dr. Ahmed Saleh, MD, FRCPC, Co-founder and Medical Director, ANSR Clinic.
ketamine
Angela -
OPA - Understanding street trauma from those that lived it Events
Ontario Psychiatric Association 2022 Expert Series -- Online CME
KETAMINE FOR PSYCHIATRIC DISORDERS: THE KNOWNS AND UNKNOWNS
Monday, February 7, 2022
7:30 pm – 9:30 pm ET
Speaker: Dr. Venkat Bhat, MD, MSc, FRCPC, DABPN
0 Replies
Angela -
OPA - Pharmacotherapy of MDD: a practical guide Events
Ontario Psychiatric Association 2022 Expert Series -- Online CME
KETAMINE FOR PSYCHIATRIC DISORDERS: THE KNOWNS AND UNKNOWNS
Monday, February 7, 2022
7:30 pm – 9:30 pm ET
Speaker: Dr. Venkat Bhat, MD, MSc, FRCPC, DABPN
0 Replies
Angela -
OPA - Ketamine for Psychiatric Disorders: the knowns and unknowns Events
Ontario Psychiatric Association 2022 Expert Series -- Online CME
KETAMINE FOR PSYCHIATRIC DISORDERS: THE KNOWNS AND UNKNOWNS
Monday, February 7, 2022
7:30 pm – 9:30 pm ET
Speaker: Dr. Venkat Bhat, MD, MSc, FRCPC, DABPN
0 Replies
It isn't New: The Role of Psilocybin and Ketamine in Youth Mental Health Treatment Events
Psychedelics such as psilocybin, lysergic acid diethylamide (LSD) and Ketamine have long been excluded from mental therapeutic treatments due to stigmatization and lack of understanding. In recent years however, researchers and scientists have begun to unearth new discoveries and research in relation to the effectiveness of these substances in the treatment of depression, anxiety, and other mental health challenges.
0 Replies